SEC-sourced researchBeta
CFOR
CapForce Inc.
Company comparison ↗
Data passport
- CIK
- 0001293818
- Exchange
- OTC
- Business activity
- Services-Medical Laboratories · SIC 8071
- Financial inputs
- 6/6
- Filing date
- Nov 16, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 5,196,149.0000 | May 26, 2026 |
| December 2025 | 30,200,000.0000 | May 26, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 30,200,000.0000 | 23,620,056.0000 | -1,183,624.0000 | 38,055,173.0000 | 6,198,515.0000 | May 26, 2026 |
| December 2024 | 5,196,149.0000 | 11,992,780.0000 | -4,869,744.0000 | 9,862,698.0000 | 2,482,070.0000 | May 26, 2026 |
Explainable fundamental score
Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.
85/100
Profitability100
Growth100
Balance sheet84
Cash generation42
Data coverage100
Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $30.2M | Jan 1, 2025 – Dec 31, 2025 | May 26, 2026 | 10-K |
| Previous period revenueRevenues | $5.2M | Jan 1, 2024 – Dec 31, 2024 | May 26, 2026 | 10-K |
| Net incomeNetIncomeLoss | $23.62M | Jan 1, 2025 – Dec 31, 2025 | May 26, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$1.18M | Jan 1, 2025 – Dec 31, 2025 | May 26, 2026 | 10-K |
| Total assetsAssets | $38.06M | Dec 31, 2025 | May 26, 2026 | 10-K |
| Total liabilitiesLiabilities | $6.2M | Dec 31, 2025 | May 26, 2026 | 10-K |